RxDoctor Payments Data

Jose Nuno, PA

Physician Assistant · Norfolk, NENPI 1760990105

Payments from drug & device makers

$766in general payments, 2019–2025

Across 47 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$130
  • AstraZeneca$97
  • Amgen$78
  • Pfizer$72
  • Biohaven Pharmaceutical Holding Company Ltd.$71
  • Itamar Medical Inc$69
  • plus $250 from 6 others

What the payments were for

  • Food & beverage$766100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$766 in reported general payments places this provider in the 65th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$15,579
Medicare patients
51
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide24$27,842
FarxigaDapagliflozin Propanediol30$23,140
MounjaroTirzepatide18$20,084
Tresiba Flextouch U-100Insulin Degludec11$10,983
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$5,992
SymbicortBudesonide/Formoterol Fumarate15$3,147
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,282
Diclofenac Sodium23$948
Ventolin HfaAlbuterol Sulfate12$680
Omeprazole47$590
Levothyroxine Sodium61$576
Metformin Hcl90$554
Pantoprazole Sodium52$506
Atorvastatin Calcium91$430
Lisinopril71$417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$60$47,92642 claims
AstraZenecaFarxiga, Symbicort$97$26,28745 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Norfolk

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →